---
figid: PMC8010885__gr6
figlink: pmc/articles/PMC8010885/figure/fig0006/
number: F6
caption: Schematic representation of cholesterol associated changes in cancer cells
  and available therapeutic targets. (A) Role of cholesterol in stemness, ROS generation,
  intestinal inflammation, migration, sphere formation, activation of different signaling
  molecules, increased angiogenesis, imparting chemo and radioresistance as well as
  reprogramming of cancer-associated immune cells. (B) Conversion of blood cholesterol
  to oxycholesterol, through enzymatic or radical oxidation. (C) Different mode of
  cholesterol uptake; pathway associated with altered cholesterol biosynthesis and
  storage of cholesterol along with different agents targeting cholesterol metabolism
  for treatment.
pmcid: PMC8010885
papertitle: Influence of cholesterol on cancer progression and therapy.
reftext: Shyamananda Singh Mayengbam, et al. Transl Oncol. 2021 Jun;14(6):101043.
pmc_ranked_result_index: '15797'
pathway_score: 0.904842
filename: gr6.jpg
figtitle: Cholesterol associated changes in cancer cells and available therapeutic
  targets
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8010885__gr6.html
  '@type': Dataset
  description: Schematic representation of cholesterol associated changes in cancer
    cells and available therapeutic targets. (A) Role of cholesterol in stemness,
    ROS generation, intestinal inflammation, migration, sphere formation, activation
    of different signaling molecules, increased angiogenesis, imparting chemo and
    radioresistance as well as reprogramming of cancer-associated immune cells. (B)
    Conversion of blood cholesterol to oxycholesterol, through enzymatic or radical
    oxidation. (C) Different mode of cholesterol uptake; pathway associated with altered
    cholesterol biosynthesis and storage of cholesterol along with different agents
    targeting cholesterol metabolism for treatment.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LDLR
  - ABCG1
  - NBPF10
  - COG2
  - SOAT1
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - SREBF2
  - EIF2AK3
  - SCARB1
  - NPC1L1
  - ABCA1
  - Cholesterol
  - cholesterol
  - Ezetimibe
  - dehydroxy
  - Mevalonate
  - Statin
  - O0OX
  - Acetoacetyl CoA
  - Acetyl
  - CoA
  - Acetyl CoA
  - methyl B-cyclodextrin
  - Hypercholesterolemia
  - Stemness
  - inflammation
  - MCD
  - cancer
genes:
- word: LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: АВСG1
  symbol: ABCG1
  source: hgnc_symbol
  hgnc_symbol: ABCG1
  entrez: '9619'
- word: АВСG1
  symbol: AG1
  source: hgnc_alias_symbol
  hgnc_symbol: NBPF10
  entrez: '100132406'
- word: LDLC
  symbol: LDLC
  source: hgnc_prev_symbol
  hgnc_symbol: COG2
  entrez: '22796'
- word: LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: ACAT
  symbol: ACAT
  source: hgnc_alias_symbol
  hgnc_symbol: SOAT1
  entrez: '6646'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SREBP2
  symbol: SREBP2
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF2
  entrez: '6721'
- word: PERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: SREBP2
  symbol: SREBP2
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF2
  entrez: '6721'
- word: LDLC
  symbol: LDLC
  source: hgnc_prev_symbol
  hgnc_symbol: COG2
  entrez: '22796'
- word: :LDLC
  symbol: LDLC
  source: hgnc_prev_symbol
  hgnc_symbol: COG2
  entrez: '22796'
- word: (LDLR,
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: :LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: SRB1
  symbol: SRB1
  source: hgnc_alias_symbol
  hgnc_symbol: SCARB1
  entrez: '949'
- word: :SRB1
  symbol: SRB1
  source: hgnc_alias_symbol
  hgnc_symbol: SCARB1
  entrez: '949'
- word: NPC1L1
  symbol: NPC1L1
  source: hgnc_symbol
  hgnc_symbol: NPC1L1
  entrez: '29881'
- word: :NPC1L1
  symbol: NPC1L1
  source: hgnc_symbol
  hgnc_symbol: NPC1L1
  entrez: '29881'
- word: ABCA1,
  symbol: ABCA1
  source: hgnc_symbol
  hgnc_symbol: ABCA1
  entrez: '19'
- word: ABCG1
  symbol: ABCG1
  source: hgnc_symbol
  hgnc_symbol: ABCG1
  entrez: '9619'
- word: NPC1L1
  symbol: NPC1L1
  source: hgnc_symbol
  hgnc_symbol: NPC1L1
  entrez: '29881'
- word: SRB1
  symbol: SRB1
  source: hgnc_alias_symbol
  hgnc_symbol: SCARB1
  entrez: '949'
chemicals:
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: cholesterol
  source: MESH
  identifier: D002784
- word: Ezetimibe
  source: MESH
  identifier: C108606
- word: dehydroxy
  source: MESH
  identifier: C581965
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: Statin
  source: MESH
  identifier: D019821
- word: O0OX
  source: MESH
  identifier: C086273
- word: Acetoacetyl CoA
  source: MESH
  identifier: C010667
- word: Acetyl
  source: MESH
  identifier: C011632
- word: CoA
  source: MESH
  identifier: C065987
- word: Acetyl CoA
  source: MESH
  identifier: D000105
- word: methyl B-cyclodextrin
  source: MESH
  identifier: C108732
diseases:
- word: Hypercholesterolemia
  source: MESH
  identifier: D006937
- word: Stemness
  source: MESH
  identifier: D020295
- word: inflammation
  source: MESH
  identifier: D007249
- word: MCD
  source: MESH
  identifier: D012514
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC8010885__F6
redirect_from: /figures/PMC8010885__F6
figtype: Figure
---
